Latest Stem cells Stories
HACKENSACK, N.J., March 21, 2013 /PRNewswire-USNewswire/ -- Parent Project Muscular Dystrophy (PPMD) has awarded University of Minnesota researcher Dr. Rita Perlingeiro a grant for $220,000 to develop a therapeutic approach for Duchenne muscular dystrophy (Duchenne) using a new type of "adult-derived" stem cell called "induced pluripotent stem cells" or "iPSCs." iPSCs can be created from non-controversial sources like skin, have the ability to multiply indefinitely, and can be...
redOrbit Staff & Wire Reports - Your Universe Online Researchers at the Stanford University School of Medicine have developed a new visualization technique which they believe could eventually help make the repair of damaged hearts through regenerative medicine a reality. In a study published in Wednesday’s edition of the journal Science Translational Medicine, senior author and Stanford radiology professor Sam Gambhir and colleagues describe how they plan to mark the stem cells...
MADISON, Wis., March 21, 2013 /PRNewswire/ -- Cellular Dynamics International (CDI) and Coriell Institute for Medical Research today announced receiving two multi-million dollar grant awards from the California Institute for Regenerative Medicine (CIRM). CIRM awarded CDI $16 million to create 3 induced pluripotent stem cell (iPSC) lines for each of 3000 healthy and diseased donors. Tissue samples will be taken from patients suffering from Alzheimer's disease, autism spectrum...
PALO ALTO, Calif., March 21, 2013 /PRNewswire/ -- Cellular Biomedicine Group (OTCQB: CBMG) announced that in the first week of March 2013, the company launched a clinical trial for TC-DC (Tumor Stem Cell Specific Dendritic Cell) therapy for hepatocellular carcinoma (HCC), the most common type of liver cancer. The clinical trial, which is already in progress, is the result of collaboration between CBMG, California Stem Cell (CSC) and Shanghai's PLA 85 Hospital. It is the first...
Leading bone marrow donor center unveils aggressive nationwide initiative under new name to boost donor numbers NEW YORK, March 21, 2013 /PRNewswire/ -- Every year, more than 12,000 patients in the U.S. are diagnosed with blood cancers for which a bone marrow transplant may be their only hope for a cure. 70% of patients in need rely on a perfect stranger for a bone marrow donation. DKMS Americas, part of the world's largest bone marrow donor center announced today that they are...
In a new study published by STEM CELLS Translational Medicine, scientists report on a way to produce natural cancer-killing cells in the lab in a quantity that could one day make them viable for treating patients. Durham, NC (PRWEB) March 20, 2013 In a new study published by STEM CELLS Translational Medicine, scientists report on a way to produce natural cancer-killing cells in the lab in a quantity that could one day make them viable for treating patients. While the production of human...
Breakthrough First of Kind Technologies Will Be Presented LOS ANGELES, March 20, 2013 /PRNewswire/ -- Heart Failure 2013 LA will be held at the Millennium Biltmore Hotel all day on Saturday April 6(th). Leonhardt Ventures and the Cal-X Stars Life Science Business Accelerator are co-sponsoring @ 5:30pm a side showcase of startups that address heart and cardiovascular disease, most of them based in Southern California or with strong SoCal ties. Companies to be showcased include:...
Ground-Breaking Clinical Trials Are Providing Families New Potential Treatment Options SAN BRUNO, Calif., March 19, 2013 /PRNewswire/ -- Cord Blood Registry® (CBR®), the world's largest newborn stem cell bank, is fueling innovation in newborn stem cell research. As CBR prepares to release its 250(th) cord blood unit for medical use this month, the newborn stem cell bank announces that 71% of all its units released for use have been for emerging applications in regenerative...
Singapore, Mar 19, 2013 - (ACN Newswire) - VeriStem Technologies, a spin-off from A*STAR's Bioprocessing Technology Institute (BTI), has been awarded the Biospectrum Asia-Pacific Emerging Companies of the Year Award 2013. Shortlisted from start-up companies spanning the biotechnology, medical technology, and pharmaceutical sectors across the Asia-Pacific region, winners are chosen for developing innovative technology that has the potential to bring out revolutionary changes in the healthcare...
Stem Cell Orthopedic Weighs in on Misinformation Within Controversial Performance Enhancing Drug Debate (PRWEB) March 16, 2013 StemCellOrthopedic.com, popular website of the Institute of Regenerative and Molecular Orthopaedics (IRMO), world renowned stem cell therapy experts, have recently written a blog tackling misinformation contained in the greater debate regarding the controversial use of performance enhancing drugs (PED) by professional athletes. In particular, Stem Cell Orthopedics...
